Walkner Condon Financial Advisors LLC Gilead Sciences, Inc. Transaction History
Walkner Condon Financial Advisors LLC
- $686 Million
- Q4 2025
A detailed history of Walkner Condon Financial Advisors LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Walkner Condon Financial Advisors LLC holds 4,005 shares of GILD stock, worth $496,980. This represents 0.07% of its overall portfolio holdings.
Number of Shares
4,005
Previous 3,941
1.62%
Holding current value
$496,980
Previous $437,000
13.5%
% of portfolio
0.07%
Previous 0.07%
Shares
13 transactions
Others Institutions Holding GILD
# of Institutions
2,408Shares Held
1.01BCall Options Held
8.51MPut Options Held
7.32M-
Vanguard Group Inc Valley Forge, PA121MShares$15 Billion0.23% of portfolio
-
Black Rock Inc. New York, NY121MShares$15 Billion0.19% of portfolio
-
State Street Corp Boston, MA59.1MShares$7.33 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA45.2MShares$5.61 Billion0.72% of portfolio
-
Dodge & Cox San Francisco, CA30.1MShares$3.74 Billion1.93% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $156B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...